iOnctura announces expansion of roginolisib clinical trial program to NSCLC ...Middle East

PR Newswire - News
Phase II study in non-small-cell-lung-cancer (NSCLC) to be run in collaboration with the ETOP IBCSG Partners Foundation across sites in Europe Study will investigate dostarlimab + roginolisib +/- docetaxel in patients with NSCLC resistant to first-line checkpoint inhibitor therapy GENEVA...

Hence then, the article about ionctura announces expansion of roginolisib clinical trial program to nsclc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( iOnctura announces expansion of roginolisib clinical trial program to NSCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News